Superb Microvascular Imaging Is Superior to Doppler Imaging in Ruling Out Ulcerative Colitis Disease Activity
Authors:
- 8 March 2025
- journal article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
Abstract
Background: There is an unmet medical need for noninvasive techniques to determine disease activity in inflammatory bowel disease (IBD) and intestinal ultrasound (IUS) has shown promising performance in this regard. In addition to parameters such as bowel wall thickness, stratification, and mesenteric fat, color Doppler signals are used to determine inflammatory activity in the gut. However, whether superb microvascular imaging (SMI), a microvascular flow imaging technique, improves the diagnostic accuracy is currently unclear. Methods: We performed a prospective single-center cross-sectional cohort study including 62 patients with ulcerative colitis (UC). IUS was performed on the sigmoid colon within 30 days of colonoscopy and the International Bowel Ultrasound (IBUS) group Segmental Activity Score (SAS) as well as SMI signals were determined and correlated to established endoscopic, clinical, and biochemical read-outs of disease activity. Results: Semiquantitative scoring of SMI signals had a substantial interobserver agreement between 2 blinded and expert central readers. It showed excellent correlation to endoscopic, clinical, and biochemical disease activity. While SMI did not improve the overall diagnostic performance of the IBUS-SAS to predict endoscopic disease activity, SMI alone was highly precise and superior to Doppler imaging in predicting endoscopic remission. Conclusions: IUS is a highly precise noninvasive diagnostic tool to monitor disease activity in UC, in particular for predicting endoscopic remission. Assessing the SMI signals in the bowel wall of patients with IBD seems a promising tool to simplify IUS diagnostics in IBD that warrants further research.Keywords
This publication has 34 references indexed in Scilit:
- AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: CommentaryClinical Gastroenterology and Hepatology, 2024
- Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to Ulcerative Colitis: A Preliminary StudyClinical Gastroenterology and Hepatology, 2024
- Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort studyeClinicalMedicine, 2024
- Superb Microvascular Imaging for the Differentiation of Benign and Malignant Breast Lesions: A System Review and Meta‐AnalysisJournal of Ultrasound in Medicine, 2022
- Diagnostic accuracy of different cross-sectional imaging techniques for disease location and activity in Crohn’s disease and external validation and comparison of MARIAs and IBUS-SASAbdominal Radiology, 2022
- Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2022
- Are we ready to use activity scores for intestinal ultrasound in ulcerative colitis?United European Gastroenterology Journal, 2021
- Clinical Applications of Superb Microvascular Imaging in the Liver, Breast, Thyroid, Skeletal Muscle, and Carotid PlaquesJournal of Ultrasound in Medicine, 2019
- Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)Digestive and Liver Disease, 2018
- Complications of diagnostic colonoscopy, upper endoscopy, and enteroscopyBest Practice & Research Clinical Gastroenterology, 2016